US274568A
(en)
|
|
1883-03-27 |
|
cunningham |
US5231185A
(en)
|
1985-11-19 |
1993-07-27 |
Cornell Research Foundation, Inc. |
Monosaccharide analog-based glycosidase inhibitors
|
US4859449A
(en)
|
1987-09-14 |
1989-08-22 |
Center For Molecular Medicine And Immunology |
Modified antibodies for enhanced hepatocyte clearance
|
EP0359096B1
(en)
|
1988-09-15 |
1997-11-05 |
The Trustees Of Columbia University In The City Of New York |
Antibodies having modified carbohydrate content and methods of preparation and use
|
JPH0667317B2
(ja)
|
1988-09-21 |
1994-08-31 |
財団法人野田産業科学研究所 |
N−アセチルヘキソサミンデヒドロゲナーゼ、その製造法及び該酵素を用いるn−アセチルグルコサミン又はn−アセチルガラクトサミンの定量法及びその定量用キット
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
US5340453A
(en)
|
1989-09-27 |
1994-08-23 |
Astroscan, Ltd. |
Analysis of carbohydrates
|
DK167813B1
(da)
|
1989-12-07 |
1993-12-20 |
Carlbiotech Ltd As |
Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
|
US5583042A
(en)
|
1990-04-16 |
1996-12-10 |
Neose Pharmaceuticals, Inc. |
Apparatus for the synthesis of saccharide compositions
|
AP249A
(en)
|
1990-04-24 |
1993-03-17 |
Biota Scient Management Pty Ltd |
Anti-viral compounds.
|
IE914075A1
(en)
|
1990-11-23 |
1992-06-03 |
Gen Hospital Corp |
Inhibition of cell adhesion protein-carbohydrate¹interactions
|
US5234905A
(en)
|
1991-02-22 |
1993-08-10 |
University Of Colorado Foundation, Inc. |
Soluble CD4 molecules modified to prolong circulating half-life
|
ATE193551T1
(de)
|
1991-03-18 |
2000-06-15 |
Scripps Research Inst |
Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen
|
US5370872A
(en)
|
1991-08-12 |
1994-12-06 |
Swiss Serum And Vaccine Institute Berne |
Escherichia coliO-polysaccharide-protein conjugate vaccine
|
WO1993005076A1
(en)
|
1991-08-30 |
1993-03-18 |
Glyko, Inc. |
Fluorophore assisted derivatization analysis of carbohydrates
|
WO1993010260A1
(en)
|
1991-11-21 |
1993-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases
|
US5456909A
(en)
|
1992-08-07 |
1995-10-10 |
T Cell Sciences, Inc. |
Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivo
|
US5554730A
(en)
|
1993-03-09 |
1996-09-10 |
Middlesex Sciences, Inc. |
Method and kit for making a polysaccharide-protein conjugate
|
SE9301677L
(sv)
|
1993-05-14 |
1994-11-18 |
Kurt G I Nilsson |
Syntesmetod
|
JPH09503905A
(ja)
|
1993-07-15 |
1997-04-22 |
ネオゼ ファーマシューティカルス |
糖組成物の合成方法
|
US5559103A
(en)
|
1993-07-21 |
1996-09-24 |
Cytel Corporation |
Bivalent sialyl X saccharides
|
JP3020811B2
(ja)
|
1993-08-23 |
2000-03-15 |
寳酒造株式会社 |
糖鎖構造決定方法
|
US5459031A
(en)
|
1993-11-05 |
1995-10-17 |
Amgen Inc. |
Methods for controlling sialic acid derivatives in recombinant glycoproteins
|
US5567684A
(en)
|
1994-09-14 |
1996-10-22 |
The Regents Of The University Of California |
Synthetic ganglioside derivatives
|
US5545553A
(en)
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
JP4429386B2
(ja)
|
1994-12-01 |
2010-03-10 |
生化学工業株式会社 |
ケラタン硫酸オリゴ糖画分及びそれを含む薬剤
|
US5985623A
(en)
|
1995-01-24 |
1999-11-16 |
Shin-Etsu Bio, Inc. |
DNA segments and methods for increasing polysaccharide production
|
US6030815A
(en)
|
1995-04-11 |
2000-02-29 |
Neose Technologies, Inc. |
Enzymatic synthesis of oligosaccharides
|
DE19527054A1
(de)
|
1995-07-26 |
1997-01-30 |
Behringwerke Ag |
Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen
|
US5753454A
(en)
|
1995-09-12 |
1998-05-19 |
Iowa State University Research Foundation, Inc. |
Sequencing of oligosaccharides: the reagent array-electrochemical detection method
|
JP4503706B2
(ja)
|
1996-06-07 |
2010-07-14 |
ポニアード ファーマシューティカルズ,インコーポレイティド |
グリコシル化が改質されたヒト化抗体
|
JP4179567B2
(ja)
|
1996-07-23 |
2008-11-12 |
生化学工業株式会社 |
新規ラクトサミンオリゴ糖およびその製造方法
|
US5994511A
(en)
|
1997-07-02 |
1999-11-30 |
Genentech, Inc. |
Anti-IgE antibodies and methods of improving polypeptides
|
US6190522B1
(en)
|
1998-04-24 |
2001-02-20 |
Board Of Regents, The University Of Texas System |
Analysis of carbohydrates derivatized with visible dye by high-resolution polyacrylamide gel electrophoresis
|
DK1084147T3
(da)
|
1998-06-09 |
2004-10-25 |
Statens Seruminstitut |
Fremgangsmåde til fremstilling af immunglobuliner til administration og andre immunglobulinprodukter
|
WO2000007602A1
(en)
|
1998-08-06 |
2000-02-17 |
The Johns Hopkins University School Of Medicine |
Compounds for altering cell surface sialic acids and methods of use therefor
|
US6949372B2
(en)
|
1999-03-02 |
2005-09-27 |
The Johns Hopkins University |
Engineering intracellular sialylation pathways
|
EP1190364A2
(en)
|
1999-04-23 |
2002-03-27 |
Massachusetts Institute Of Technology |
System and method for polymer notation
|
EP1171615B1
(en)
|
1999-04-26 |
2006-12-13 |
Genentech, Inc. |
Cell culture process for glycoproteins
|
US6280989B1
(en)
|
1999-06-17 |
2001-08-28 |
Dmitri Kapitonov |
Sialyltransferases
|
US6261805B1
(en)
|
1999-07-15 |
2001-07-17 |
Boyce Thompson Institute For Plant Research, Inc. |
Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
|
CN1437478A
(zh)
|
2000-04-25 |
2003-08-20 |
Idec药物公司 |
瑞图希单抗的鞘内施用,用于中枢神经***淋巴瘤的治疗
|
US7795002B2
(en)
|
2000-06-28 |
2010-09-14 |
Glycofi, Inc. |
Production of galactosylated glycoproteins in lower eukaryotes
|
KR100787073B1
(ko)
|
2000-06-28 |
2007-12-21 |
글리코파이, 인크. |
변형된 당단백질의 제조방법
|
US6946292B2
(en)
|
2000-10-06 |
2005-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
|
US6394785B1
(en)
|
2000-11-20 |
2002-05-28 |
Top Grade Molds Ltd. |
Nozzle for injection mold
|
EP1373547A4
(en)
|
2001-03-27 |
2006-01-18 |
Smithkline Beecham Corp |
CONTROL OF GLYCOFORMS IN IGG
|
PL222211B1
(pl)
|
2001-06-26 |
2016-07-29 |
Amgen Fremont Inc |
Przeciwciało przeciwko OPGL, kompozycja je zawierająca, jego zastosowanie i sposób jego wytwarzania, sposób wykrywania poziomu OPGL, kompozycja obejmująca polinukleotydy i komórka gosodarza
|
US20030096281A1
(en)
|
2001-09-14 |
2003-05-22 |
Ganesh Venkataraman |
Methods of making glycomolecules with enhanced activities and uses thereof
|
ES2326964T3
(es)
|
2001-10-25 |
2009-10-22 |
Genentech, Inc. |
Composiciones de glicoproteina.
|
ES2402527T3
(es)
|
2001-12-27 |
2013-05-06 |
Glycofi, Inc. |
Procedimientos para obtener estructuras de carbohidrato de tipo mamífero mediante ingeniería genética
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
ATE445709T1
(de)
|
2002-10-16 |
2009-10-15 |
Scripps Research Inst |
Glycoproteinsynthese
|
US20040208870A1
(en)
|
2003-01-30 |
2004-10-21 |
Medimmune, Inc. |
Stabilized high concentration anti-integrin alphanubeta3 antibody formulations
|
EP1467299A3
(en)
|
2003-03-28 |
2005-02-09 |
Solutia Inc. |
Methods and structure for automated active pharmaceuticals development
|
US20070026485A1
(en)
|
2003-04-09 |
2007-02-01 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
CN1871259A
(zh)
*
|
2003-08-22 |
2006-11-29 |
比奥根艾迪克Ma公司 |
具有改变的效应物功能的经改进的抗体和制备它的方法
|
US20060127950A1
(en)
|
2004-04-15 |
2006-06-15 |
Massachusetts Institute Of Technology |
Methods and products related to the improved analysis of carbohydrates
|
WO2005111627A2
(en)
*
|
2004-04-15 |
2005-11-24 |
Massachusetts Institute Of Technology |
Methods and products related to the improved analysis of carbohydrates
|
KR100542605B1
(ko)
|
2004-05-28 |
2006-01-11 |
보령제약 주식회사 |
에이치씨티엘에이4-아이지 융합단백질 유전자를 포함하는재조합 벡터 및 이를 이용한 에이치씨티엘에이4-아이지융합 단백질의 생산방법
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
WO2006107990A2
(en)
|
2005-04-05 |
2006-10-12 |
The Johns Hopkins University |
Improving protein n-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other n-gylosylation-increasing methods, and engineered hosts expressing products with increased n-glycosylation
|
US8759005B2
(en)
|
2005-07-11 |
2014-06-24 |
Glykos Finland Oy |
Tissue carbohydrate compositions and analysis thereof
|
EP1921090B1
(en)
|
2005-07-22 |
2015-01-14 |
Kyowa Hakko Kirin Co., Ltd. |
Genetically modified antibody composition
|
US20080206246A1
(en)
|
2006-04-05 |
2008-08-28 |
Ravetch Jeffrey V |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
AU2006312148B2
(en)
|
2005-11-07 |
2012-04-12 |
The Rockefeller University |
Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
|
US8470318B2
(en)
|
2005-11-07 |
2013-06-25 |
The Rockefeller University |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
PL2253644T3
(pl)
|
2005-12-20 |
2014-04-30 |
Bristol Myers Squibb Co |
Kompozycje i sposoby wytwarzania kompozycji
|
AR058567A1
(es)
|
2005-12-20 |
2008-02-13 |
Bristol Myers Squibb Co |
Formulaciones de proteinas estables
|
US20070190057A1
(en)
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
EP2815768A3
(en)
|
2006-04-05 |
2015-01-14 |
The Rockefeller University |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
EP2035034A4
(en)
|
2006-06-09 |
2009-11-18 |
Univ Maryland |
GLYCOSYLATION-CONTROLLED ANTIBODY THERAPY
|
AU2007264846A1
(en)
|
2006-06-29 |
2008-01-03 |
Glykos Finland Oy |
Novel cellular glycan compositions
|
NZ597651A
(en)
*
|
2006-10-26 |
2012-07-27 |
Univ Rockefeller |
Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
|
EP2091969A4
(en)
|
2006-10-27 |
2010-05-12 |
Univ Rockefeller |
POLYPEPTIDES WITH IMPROVED INFLAMMATORY INHIBITION AND REDUCED CYTOTOXIC PROPERTIES AND RELATED METHODS THEREFOR
|
BRPI0717335A2
(pt)
|
2006-10-27 |
2013-12-10 |
Abbott Biotech Ltd |
Anticorpos anti-htnfalfa cristalinos
|
WO2008063982A2
(en)
|
2006-11-13 |
2008-05-29 |
Procell Corp |
High mannose glycoprotein epitopes
|
AU2007338013A1
(en)
|
2006-12-22 |
2008-07-03 |
Ares Trading S.A. |
Analytical method for analyzing C-terminus truncation
|
WO2008120107A2
(en)
|
2007-04-03 |
2008-10-09 |
Oxyrane (Uk) Limited |
Glycosylation of molecules
|
RU2475759C2
(ru)
|
2007-04-16 |
2013-02-20 |
Момента Фармасьютикалз, Инк. |
Исследование n-гликанов с использованием экзогликозидаз
|
RU2475751C2
(ru)
|
2007-04-16 |
2013-02-20 |
Момента Фармасьютикалз, Инк. |
Способы, связанные с гликозилированием клеточной поверхности
|
US20100279306A1
(en)
|
2007-04-16 |
2010-11-04 |
Momenta Pharmaceuticals, Inc. |
Analysis of phosphorylated glycans, glycopeptides or glycoproteins by imac
|
US20110213137A1
(en)
|
2007-04-16 |
2011-09-01 |
Momenta Pharmaceuticals, Inc. |
Isotopically-labeled glycans
|
US9182467B2
(en)
|
2007-04-16 |
2015-11-10 |
Momenta Pharmaceuticals, Inc. |
Comparative analysis of protein conformations by using 2D NOESY NMR spectra
|
US20120264927A1
(en)
|
2007-04-16 |
2012-10-18 |
Ian Christopher Parsons |
Methods for labeling glycans
|
AU2008240078B2
(en)
|
2007-04-16 |
2012-10-25 |
Momenta Pharmaceuticals, Inc. |
Multi-dimensional chromatographic methods for separating N-glycans
|
CA2682738A1
(en)
|
2007-04-16 |
2008-10-23 |
Momenta Pharmaceuticals, Inc. |
Defined glycoprotein products and related methods
|
EP2135088A1
(en)
|
2007-04-16 |
2009-12-23 |
Momenta Pharmaceuticals, Inc. |
Characterization of n-glycan mixtures by nuclear magnetic resonance
|
CA2682750A1
(en)
|
2007-04-16 |
2008-10-23 |
Momenta Pharmaceuticals, Inc. |
Ms methods to evaluate glycans
|
WO2008128230A1
(en)
|
2007-04-16 |
2008-10-23 |
Momenta Pharmaceuticals, Inc. |
Reference glycoprotein products and related methods
|
EP2135090A1
(en)
|
2007-04-16 |
2009-12-23 |
Momenta Pharmaceuticals, Inc. |
Proteolytic release of glycans
|
ES2477271T3
(es)
|
2007-08-13 |
2014-07-16 |
Baxter International Inc. |
Modulación por IVIG de quimioquinas para el tratamiento de la esclerosis múltiple, la enfermedad de Alzheimer y la enfermedad de Parkinson
|
PL2612868T3
(pl)
|
2007-11-01 |
2018-12-31 |
Astellas Pharma Inc. |
Immunosupresyjne polipeptydy i kwasy nukleinowe
|
US8278072B1
(en)
|
2007-11-19 |
2012-10-02 |
Health Research, Inc. |
Method for synthesis of sialylated products using reversible sialylation
|
TWI489994B
(zh)
|
2008-03-17 |
2015-07-01 |
Baxter Healthcare Sa |
供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
|
CL2009000843A1
(es)
|
2008-04-11 |
2009-07-24 |
Galaxy Biotech Llc |
Metodo para tratar cancer en un paciente que comprende la administracion de un primer agente que es inhibidor de factor de crecimiento de hepatocito (hgf) en combinacion con un segundo agente que es inhibidor de una ruta de senalizacion celular diferente de la ruta hgf/cmet.
|
CN102037356A
(zh)
*
|
2008-04-22 |
2011-04-27 |
洛克菲勒大学 |
鉴定抗炎化合物的方法
|
KR20110084196A
(ko)
|
2008-09-26 |
2011-07-21 |
유레카 쎄라퓨틱스, 인코포레이티드 |
다양한 글리코실화 패턴을 가진 세포계 및 단백질
|
CN102239173A
(zh)
|
2008-12-19 |
2011-11-09 |
动量制药公司 |
与修饰的聚糖相关的方法
|
WO2010071817A2
(en)
|
2008-12-19 |
2010-06-24 |
Momenta Pharmaceuticals, Inc. |
Characterization of o-linked glycans
|
KR20110119702A
(ko)
|
2009-01-22 |
2011-11-02 |
모멘타 파머슈티컬스 인코포레이티드 |
Cho 세포에서 유도된 글리코단백질 생성물에서의 갈락토오스-알파-1,3-갈락토오스-함유 n-글리칸
|
EP2233499A1
(en)
|
2009-03-26 |
2010-09-29 |
CSL Behring AG |
Antibody composition with altered Fab sialylation
|
EP2233502A1
(en)
|
2009-03-27 |
2010-09-29 |
Deutsches Rheuma-Forschungszentrum Berlin |
Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them
|
CA2761457A1
(en)
|
2009-05-12 |
2010-11-18 |
Transgene Sa |
Immortalized avian cell lines and use thereof
|
WO2010138502A2
(en)
|
2009-05-26 |
2010-12-02 |
Momenta Pharmaceuticals, Inc. |
Production of glycoproteins
|
KR20140014405A
(ko)
|
2009-05-28 |
2014-02-06 |
글락소 그룹 리미티드 |
안구 질병을 치료하거나 예방하는데 사용되는 tnf-알파 길항제 및 vegf 길항제의 조합물
|
EP2438185A4
(en)
|
2009-06-05 |
2016-10-05 |
Momenta Pharmaceuticals Inc |
METHODS FOR MODULATING FUCOSYLATION OF GLYCOPROTEINS
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
EP2507627A2
(en)
|
2009-12-04 |
2012-10-10 |
Momenta Pharmaceuticals, Inc. |
Antennary fucosylation in glycoproteins from cho cells
|
JP5705242B2
(ja)
|
2010-02-19 |
2015-04-22 |
ゼンコア インコーポレイテッド |
新規ctla4−ig免疫アドヘシン
|
EP2555801A4
(en)
|
2010-04-07 |
2014-02-26 |
Momenta Pharmaceuticals Inc |
SELECTION AND USE OF HOST CELLS FOR THE MANUFACTURE OF GLYCOPROTEINS
|
BR112012025645A2
(pt)
|
2010-04-07 |
2017-12-12 |
Momenta Pharmaceuticals Inc |
glicanos de alta manose.
|
US8524217B2
(en)
|
2010-05-11 |
2013-09-03 |
Merck Sharp & Dohme Corp. |
MCP1-Ig fusion variants
|
AR085302A1
(es)
*
|
2011-02-24 |
2013-09-18 |
Sanofi Sa |
Metodo de produccion de anticuerpos sialilados
|
WO2012121041A1
(ja)
|
2011-03-04 |
2012-09-13 |
株式会社糖鎖工学研究所 |
シアル酸含有糖鎖の製造方法
|
GB201103955D0
(en)
|
2011-03-09 |
2011-04-20 |
Antitope Ltd |
Antibodies
|
US9170249B2
(en)
*
|
2011-03-12 |
2015-10-27 |
Momenta Pharmaceuticals, Inc. |
N-acetylhexosamine-containing N-glycans in glycoprotein products
|
US9434786B2
(en)
|
2012-02-10 |
2016-09-06 |
University Of Maryland, Baltimore |
Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
|
EP2841452B1
(en)
|
2012-04-25 |
2023-04-12 |
Momenta Pharmaceuticals, Inc. |
Modified glycoproteins
|
WO2014018747A2
(en)
|
2012-07-26 |
2014-01-30 |
Momenta Pharmaceuticals, Inc. |
Glycoproteins with anti-inflammatory properties
|
US20150252108A1
(en)
|
2012-09-26 |
2015-09-10 |
Momenta Pharmaceuticals, Inc. |
Glycoprotein preparations
|
US9217168B2
(en)
|
2013-03-14 |
2015-12-22 |
Momenta Pharmaceuticals, Inc. |
Methods of cell culture
|
EP2991666B1
(en)
|
2013-05-02 |
2020-03-25 |
Momenta Pharmaceuticals, Inc. |
Sialylated glycoproteins
|
WO2014186310A1
(en)
|
2013-05-13 |
2014-11-20 |
Momenta Pharmaceuticals, Inc. |
Methods for the treatment of neurodegeneration
|
WO2014191240A1
(en)
|
2013-05-29 |
2014-12-04 |
F. Hoffmann-La Roche Ag |
Quantitative control of sialylation
|
EP3017057B1
(en)
|
2013-07-05 |
2019-10-02 |
F.Hoffmann-La Roche Ag |
Process for the mono- and bi-sialylation of glycoproteins employing n-terminally truncated beta-galactoside alpha-2,6-sialyltransferase mutants
|
US20160257754A1
(en)
|
2013-10-16 |
2016-09-08 |
Momenta Pharmaceuticals Inc. |
Sialylated glycoproteins
|
WO2020077298A1
(en)
|
2018-10-11 |
2020-04-16 |
Momenta Pharmaceuticals, Inc. |
Treatment with highly silylated igg compositions
|